Tarafenacin D-tartrate
[(3R)-1-azabicyclo[2.2.2]octan-3-yl] N-(3-fluorophenyl)-N-[(3,4,5-trifluorophenyl)methyl]carbamate;(2S,3S)-2,3-dihydroxybutanedioic acid
Molecular Identity
Tarafenacin D-tartrate
[(3R)-1-azabicyclo[2.2.2]octan-3-yl] N-(3-fluorophenyl)-N-[(3,4,5-trifluorophenyl)methyl]carbamate;(2S,3S)-2,3-dihydroxybutanedioic acid
PubChem CID: 42622929
2D Structure
Properties
C25H26F4N2O8
Molecular Formula
558.50
Molecular Weight
g/mol
558.1625
Exact Mass
Da
148
TPSA
May have limited oral absorption
4
H-Bond Donors
13
H-Bond Acceptors
697
Complexity
SMILES
Canonical SMILES
SMILES: C1CN2CCC1C(C2)OC(=O)N(CC3=CC(=C(C(=C3)F)F)F)C4=CC(=CC=C4)F.C(C(C(=O)O)O)(C(=O)O)OIsomeric SMILES
SMILES: C1CN2CCC1[C@H](C2)OC(=O)N(CC3=CC(=C(C(=C3)F)F)F)C4=CC(=CC=C4)F.[C@H]([C@@H](C(=O)O)O)(C(=O)O)OSynonyms(16)
Tarafenacin D-tartrate1159101-48-0Tarafenacin (D-tartrate)SVT-40776[(3R)-1-azabicyclo[2.2.2]octan-3-yl] N-(3-fluorophenyl)-N-[(3,4,5-trifluorophenyl)methyl]carbamate;(2S,3S)-2,3-dihydroxybutanedioic acidorb1706581DTXSID10655222C25H26F4N2O8HY-14825AMFCD28347505AKOS030526279DA-67927MS-30159T16989(2S,3S)-2,3-Dihydroxybutanedioic acid--(3R)-1-azabicyclo[2.2.2]octan-3-yl (3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]carbamate (1/1)
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Tarafenacin D-tartrate
Loading drug network...